OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 46 filers reported holding OVID THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41 | +2.5% | 10,780 | -9.8% | 0.00% | – |
Q2 2023 | $40 | -99.9% | 11,955 | +45.5% | 0.00% | – |
Q3 2021 | $28,000 | -79.6% | 8,218 | -76.7% | 0.00% | – |
Q2 2021 | $137,000 | -14.9% | 35,227 | -12.1% | 0.00% | – |
Q1 2021 | $161,000 | +360.0% | 40,077 | +160.9% | 0.00% | – |
Q4 2020 | $35,000 | -76.2% | 15,359 | -40.1% | 0.00% | – |
Q3 2020 | $147,000 | -15.0% | 25,635 | +8.7% | 0.00% | – |
Q2 2020 | $173,000 | – | 23,574 | +8729.2% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 267 | -92.8% | 0.00% | – |
Q1 2019 | $7,000 | -75.0% | 3,723 | -24.6% | 0.00% | – |
Q3 2018 | $28,000 | +154.5% | 4,938 | +247.7% | 0.00% | – |
Q2 2018 | $11,000 | -38.9% | 1,420 | -44.1% | 0.00% | – |
Q1 2018 | $18,000 | +125.0% | 2,538 | +216.9% | 0.00% | – |
Q4 2017 | $8,000 | +700.0% | 801 | +578.8% | 0.00% | – |
Q3 2017 | $1,000 | – | 118 | +2850.0% | 0.00% | – |
Q2 2017 | $0 | – | 4 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |